drugset / Trial / NCT00660959

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia

NCT00660959 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The present study is designed to confirm and extend the observation from previous studies that lixivaptan therapy corrects hyponatremia, in euvolemic subject, including subjects with SIADH.

Timeline

Start
2008-04
Primary completion
2010-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Lixivaptan Small molecule — Oral

Indications

No indication recorded.